Solei is a leading cannabis wellness and lifestyle brand with thoughtfully designed products for curating sensorial experiences based on what you need, when you need it, entirely on your terms. Beloved by consumers for its carefully formulated products and innovative formats, Solei products feature varied and rare cannabinoids that allow you to fine-tune your routines with ease. Explore a true sense of well-being with a wide range of formats including Solei's best-selling CBD oils, ready-to-go pre-roll mult ...

Canadian cannabis producer Tilray Brands (TLRY) is the Canadian market share leader and continues to add new products. With the U.S. getting closer to reclassifying cannabis as a less regulated drug, is TLRY stock a bargain buy now? X Tilray has been easing. The pullback follows a 2.4% jump on May 16, after President Joe Biden tweeted on X that his administration "took a major step to reclassify marijuana." On May 16, the U.S. Department of Justice submitted proposed for new regulations that reclassify cann ...

Despite a broad rally in cannabis, this top Canadian LP has failed to join the party. Last week marked a historic moment for the financial markets as the Dow Jones Industrial Average soared to unprecedented heights, and the S&P 500 continued its impressive bull run, now nearing two years. Amidst this financial fervor, a particular industry has been making waves, albeit more quietly -- cannabis stocks. In 2024, these stocks have not only kept pace but have outshone these benchmark indices in many instances. ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended February 29, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 TILRAY BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of Delaware 82-4 ...

Financial Data and Key Metrics - Beverage alcohol gross profit increased to $18.9 million from $10 million, but gross margin decreased to 34% from 48% due to lower margins from craft brands [1] - Adjusted gross margin fell to 38% from 53%, primarily due to co-manufacturing agreements for brewing [1] - Net cannabis revenue increased by 14% organically, with contributions from HEXO and Truss acquisitions, offset by the elimination of $8.7 million in advisory services revenue [2] - Wellness gross profit rose to $4.1 million from $3.7 million, with gross margin holding steady at 30% [4] - Q3 total net revenue rose to $188.3 million, representing almost 30% growth year-over-year [130] - Adjusted EBITDA was $10.2 million, down from $13.3 million in the prior year quarter [137] Business Line Data and Key Metrics - Beverage alcohol revenue increased 165% to $54.7 million, driven by contributions from newly acquired craft brands [223] - Cannabis gross profit was $20.9 million, with a gross margin of 33%, compared to negative $32.8 million in the prior year quarter [140] - Wellness revenue grew 12% to $13.4 million, driven by targeted advertising campaigns and innovation efforts [141] - Distribution revenue decreased 13% to $56.8 million, impacted by infrastructure outages and weather [108] Market Data and Key Metrics - In Germany, Tilray holds the leading cannabis market share by revenue and is well-positioned to capture growth in the medical market [65] - The European medical cannabis market is projected to be a $45 billion opportunity in the long term [88] - Tilray is the fifth-largest craft brewer in the U.S., with a 4.5% market share, and aims to become a top 12 beverage company [114][123] - In Canada, Tilray maintains the number one market share in cannabis, with leading positions in key provinces and product categories [118] Company Strategy and Industry Competition - Tilray's strategy focuses on organic growth, strategic acquisitions, and cost management to drive profitability [83] - The company is leveraging its global expertise in cannabis to capitalize on regulatory changes, such as potential rescheduling in the U.S. [80] - Tilray is expanding its beverage portfolio beyond alcohol into categories like sparkling water and energy drinks [125] - The company is working to improve margins in its beverage business by moving away from co-manufacturing agreements and increasing production efficiency [96] Management Commentary on Operating Environment and Future Outlook - Management highlighted the impact of dry January on the beverage alcohol business and the challenges of integrating lower-margin craft brands [14] - The company is optimistic about the German market, where regulatory changes are expected to significantly expand the medical cannabis market [121] - Tilray is prepared to capitalize on potential U.S. regulatory changes, including rescheduling and federal legalization of medical cannabis [122] - Management expects strong growth in Q4, driven by seasonality and new product launches [5] Other Important Information - Tilray achieved $27.5 million in annualized cost savings from the HEXO integration, with $15.6 million realized in Q3 [105] - The company is working to reduce its debt, having decreased net debt to $175 million and reducing annual interest expense by $9.8 million [70] - Tilray is exploring opportunities to introduce hemp-based delta-9 beverages in the U.S. [82] Q&A Session Summary Question: Impact of excise tax changes in Canada - Management expects potential savings of $80 million annually if excise tax reforms are implemented, which would benefit Tilray and the broader industry [79][195] - The company believes that tax savings should be reinvested into the industry to drive growth and innovation [207] Question: Outlook for the German cannabis market - Tilray is well-positioned in Germany with a cultivation facility, distribution network, and strong market share [65][144] - The company expects significant growth in the German medical cannabis market due to regulatory changes [121] Question: Guidance and margin expectations - Management revised adjusted EBITDA guidance to $60-63 million, citing challenges in Q3 and expectations for a strong Q4 [170] - Margins are expected to improve in Q4 due to increased production and sales volume, particularly in the beverage alcohol business [193] Question: U.S. regulatory changes and opportunities - Tilray is prepared to enter the U.S. market if cannabis is rescheduled, leveraging its global expertise and distribution network [80][122] - The company sees significant opportunities in hemp-based delta-9 beverages and other THC-infused products [200]

EXHIBIT 99.1 Tilray Brands, Inc. Reports Q3 Fiscal 2024 Financial Results Achieved Net Revenue of $188 Million, ~ 30% Net Revenue Growth Over the Prior Year Quarter Beverage-Alcohol Net Revenue Increases 165% Over the Prior Year Quarter, 5th Largest Craft Beer Brewer in the U.S. with 4.5% Craft Beer Market Share Global Cannabis Net Revenue Increases 33% with International Cannabis Growth of 44% Over the Prior Year Quarter, #1 Market Share in Canada and #1 Market Share in Germany U.S. Cannabis Strategy in Pl ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38594 TILRAY BRANDS, INC. (Exact Name of Registrant as Specified in its Charter) (State or other jurisdiction of incorporation ...

Tilray Brands, Inc. (NASDAQ:TLRY) Q2 2024 Earnings Conference Call January 9, 2024 8:30 AM ET Company Participants Berrin Noorata - Chief Corporate Affairs and Communications Officer Irwin Simon - Chairman and Chief Executive Officer Carl Merton - Chief Financial Officer Denise Faltischek - Chief Strategy Officer and Head of International Conference Call Participants Andrew Carter - Stifel Aaron Grey - Alliance Global Partners Tamy Chen - BMO Capital Markets Owen Bennett - Jefferies John Zamparo - CIBC Matt ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) Leamington, ON N8H 5L4 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (844) 845-7291 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission Fil ...

Financial Data and Key Metrics Changes - The company reported a record Q1 with net revenue of $177 million, representing a 15% year-over-year growth [57] - Adjusted EBITDA was $11.4 million, down from $13.5 million in the prior-year quarter, primarily due to the absence of HEXO advisory fee revenue [86] - Gross profit was $44.2 million compared to $48.6 million in the prior-year quarter, with gross margin decreasing to 25% from 32% [85] Business Line Data and Key Metrics Changes - Cannabis gross revenue increased by 20%, with Canadian adult-use cannabis revenue rising by 22% [83][73] - Beverage alcohol revenue was $24.2 million, up 17% from the prior-year quarter, driven by contributions from the Montauk brewery acquisition [119] - Wellness segment revenue held steady at $13.3 million compared to $13.4 million in the prior-year quarter [120] Market Data and Key Metrics Changes - The company grew Canadian cannabis revenue by 16.5% in the quarter, maintaining a 13.4% market share in Canada [57] - International cannabis revenue grew by 37%, with significant market shares in Germany, Poland, and Luxembourg [57] - The beverage alcohol market is projected to grow significantly, with craft beer expected to reach $282 billion globally by 2032 [63] Company Strategy and Development Direction - The company aims to maximize profitable revenue growth through organic expansion and strategic acquisitions [55] - Focus on optimizing asset utilization and cost management to ensure a lean cost structure across all business segments [56] - The company is excited about the beverage category, particularly THC beverages, and plans to transition production to its London facility for cost savings [61] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the Canadian cannabis market, noting a significant shift of consumers to the legal market [30] - The company is focused on driving organic growth through new product innovation and distribution expansion [25] - Management highlighted the importance of maintaining a strong balance sheet and cash position while pursuing growth opportunities [56] Other Important Information - The company achieved $27 million in planned synergies from the HEXO transaction within two months [60] - The wellness segment is adapting to higher ingredient costs through increased pricing [107] - The company has a diversified business model, with cannabis and distribution each representing about 40% of total revenue [84] Q&A Session Summary Question: Can you speak to the margin evolution in the beverage alcohol segment? - Management indicated confidence that beer brands will maintain margins above 50%, while spirits margins are traditionally closer to 50% [127] Question: Can you clarify the liability regarding Double Diamond and its payment structure? - Management clarified that dividends issued to partners in Aphria Diamond are profit distributions and not operating expenses [129]